Industry panel: avoid one-size-fits-all approach to OTC derivatives
A panel of industry experts on June 9 urged the US House Financial Services Subcommittee to steer clear of broad, one-size-fits-all regulation for over-the-counter derivatives.
Testifying before the subcommittee, Timothy Murphy, foreign currency risk manager at consumer products company 3M, underlined the importance of OTC derivatives to companies looking to manage their exposure to foreign exchange, interest rates and commodities, and voiced "strong concerns" about the impact regulation could have on the market. He emphasised that not all OTC derivatives were involved in triggering or exacerbating the financial crisis, and therefore "not all OTC derivatives should be treated the same".
Murphy - whose views were echoed by Don Thompson, managing director and associate general counsel at JP Morgan - opposed any mandate to transfer all derivatives to clearing houses or exchanges. Thompson warned the standardisation of OTC derivatives - which moves towards clearing and exchanges would require - would "limit [companies'] ability to manage risk". In particular, companies would be required to dynamically post collateral - potentially increasing operating costs - and would not qualify for hedge accounting, leaving them open to market volatility.
Moreover, most panel members were keen to stress the benefits of companies being able to have OTC derivatives tailored to their needs. "Customisation does not necessarily mean complexity," explained Thompson.
Robert Pickel, chief executive of the International Swaps and Derivatives Association, underlined the work Isda and the industry had already undertaken with respect to standardisation. Pickel pledged continued support to regulators in helping develop further regulation for the OTC derivatives market, while underlining the market's central role in the financial services industry.
Meanwhile, Christian Johnson, professor at the University of Utah School of Law, warned against overly harsh regulation, as the OTC derivatives market is a "truly global industry that will move towards wherever it is easiest to trade".
In opening remarks, the majority of the subcommittee acknowledged the importance of OTC derivatives to risk management practices for US companies. Republican congressman Tom Price said: "When used appropriately, [derivatives] can be a very effective risk management tool." Price also accepted the particular importance of OTC derivatives and cautioned against implementing one-size-fits-all regulatory measures.
This positive view of OTC derivatives was not shared by all subcommittee members, however. "At best these derivatives are insurance; at worse they are a bet at the casino," said Democrat congressman Brad Sherman.
See also: Geithner outlines regulations for over-the-counter market
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
More on Risk management
Falling T2 balances bode well for eurozone’s stability
Impact of fragmentation would be less severe today than in 2010s, says Marcello Minenna
For a growing number of banks, synthetics are the real deal
More lenders want to use SRTs to offload credit risk, but old hands say they have a long road ahead
Did Fed’s stress capital buffer blunt CCAR?
Experts fear flagship test’s use as a capital top-up has undermined its role in risk management
How Ally found the key to GenAI at the bottom of a teacup
Risk-and-tech chemistry – plus Microsoft’s flexibility – has seen US lender leap from experiments to execution
Industry urges focus on initial margin instead of intraday VM
CPMI-Iosco says scheduled variation margin is better than ad hoc calls by clearing houses
Consortium backs BGC’s effort to challenge CME
Banks and market-makers – including BofA, Citi, Goldman, Jump and Tower – will have a 26% stake in FMX
Revealed: the three EU banks applying for IMA approval
BNP Paribas, Deutsche Bank and Intesa Sanpaolo ask ECB to use internal models for FRTB
FICC takes flak over Treasury clearing proposal
Latest plans would still allow members to bundle clearing and execution – and would fail to boost clearing capacity, critics say
Most read
- Industry urges focus on initial margin instead of intraday VM
- For a growing number of banks, synthetics are the real deal
- Did Fed’s stress capital buffer blunt CCAR?